Copper stimulates growth of human umbilical vein endothelial cells in a vascular endothelial growth factor-independent pathway

Experimental Biology and Medicine

Volumn 237, Issue 1, 2012, Pages 77-82

  Li, Shun ^a   Xie, Huiqi ^a,b   Li, Shengfu ^b   Kang, Y James ^a,b,c  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c University of Louisville School of Medicine   (United States)

Author keywords

Cell growth; Copper; eNOS; Gene silencing; VEGF

Indexed keywords

CHELATING AGENT; COPPER; COPPER SULFATE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; SMALL INTERFERING RNA; TETRAETHYLENEPENTAMINE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ARTICLE; CELL COUNT; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GROWTH STIMULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PROTEIN FUNCTION; RNA INTERFERENCE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIBODIES, MONOCLONAL; CELL CYCLE; CELL LINE; CELL PROLIFERATION; COPPER; COPPER SULFATE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862920078     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011267     Document Type: Article

References (29)

1. Jiang Y, Reynolds C, Xiao C, Feng W, Zhou Z, Rodriguez W, Tvaqi SC, Eaton JW, Saari JT, Kang YJ. Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J Exp Med 2007;204:657-66.
2. Zhou Z, Johnson WT, Kang YJ. Regression of copper-deficient heart hypertrophy: reduction in the size of hypertrophic cardiomyocyes. J Nutr Biochem 2009;20:621-8.
3. Zhou Y, Jiang Y, Kang YJ. Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size. J Mol Cell Cardiol 2008;45:106-17.
4. Zhou Y, Bourcy K, Kang YJ. Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway. Cardiovasc Res 2009;84:54-63.
5. Madonna R, De Caterina R. VEGF receptor switching in heart development and disease. Cardiovasc Res 2009;84:4-6.
6. Xie H, Kang YJ. Role of copper in angiogenesis and its medicinal implications. Curr Med Chem 2009;16:1304-14.
7. Hu GF. Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem 1998;69:326-35.
8. Juarez JC, Betancourt O Jr, Pirie-Shepherd SR, Guan X, Price ML, Shaw DE, Mazar AP, Doñate F. Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1. Clin Cancer Res 2006;12:4974-82.
9. Gérarda C, Bordeleaua LJ, Barraletb J, Doillona CJ. The stimulation of angiogenesis and collagen deposition by copper. Biomaterials 2010;31: 824-31.
10. Lowndes SA, Sheldon HV, Cai S, Taylor JM, Harris AL. Copper chelator ATN-224 inhibits endothelial function by multiple mechanisms. Microvasc Res 2009;77:314-26.
11. Watt NT, Hooper NM. The response of neurones and glial cells to elevated copper. Brain Res Bull 2001;55:219-24.
12. Mazon AF, Nolan DT, Lock RA, Fernandes MN, Wendelaar Bonga SE. A short-term in vitro gill culture system to study the effects of toxic (copper) and non-toxic (cortisol) stressors on the rainbow trout, Oncorhynchus mykiss (Walbaum). Toxicol Vitro 2004;18:691-701.
13. Lingen MW. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med 2001;125:67-71.
14. Sen CK, Khanna S, Vwnojarvi M, Trikha P, Ellison EC, Hunt TK, Rov S. Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol Heart Circ Physiol 2002;282:H1821-7.
15. Shizukuda Y, Tang S, Yolota R, Ware JA. Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase C delta activity. Circ Res 1999;85:247-56.
16. Sho E, Komatsu M, Sho M, Nanjo H, Singh TM, Xu C, Masuda H, Zarins CK. High flow drives vascular endothelial cell proliferation during flow-induced arterial remodeling associated with the expression of vascular endothelial growth factor. Exp Mol Pathol 2003;75:1-11.
17. Funovics P, Brostjan C, Niqisch A, Fila A, Grochot A, Mleczko K, Was H, Weiqel G, Dulak J, Jozkowicz A. Effects of 15d-PGJ(2) on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cells. Prostaglandins Other Lipid Mediat 2006;79:230-44.
18. Zheng ZZ, Liu ZX. Activation of the phosphatidylinositol 3-kinase/ protein kinase Akt pathway mediates CD151-induced endothelial cell proliferation and cell migration. Int J Biochem Cell Biol 2007;39:340-8.
19. Li C, Ruan L, Sood SG, Papapetropoulos A, Fulton D, Venema RC. Role of eNOS phosphorylation at Ser-116 in regulation of eNOS activity in endothelial cells. Vasc Pharmacol 2007;47:257-64.
20. Polytarchou C, Papadimitriou E. Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity. Eur J Pharmacol 2005;510:31-8.
21. Feng W, Ye F, Xue W, Zhou Z, Kang YJ. Copper regulation of hypoxia-inducible factor-1 activity. Mol Pharmacol 2009;75:174-82.
22. Martin F, Linden T, Katschinski DM, Oehme F, Flamme I, Mukhopadhyay CK, Eckhardt K, Tröger J, Barth S, Camenisch G, Wenger RH. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood 2005;105:4613-9.
23. Li Q, Chen H, Huang X, Costa M. Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1alpha) and HIF-regulated genes. Toxicol Appl Pharmacol 2006;213:245-55.
24. Traister A, Abashidze S, Gold V, Plachta N, Karchovsky E, Patel K, Weil M. Evidence that nitric oxide regulates cell-cycle progression in the developing chick neuroepithelium. Dev Dyn 2002;225:271-6.
25. Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor-1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998;95:7987-92.
26. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Targeting of HIF-1alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292:468-72.
27. Tanimoto K, Makino Y, Pereira T, Poellinger L. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 2000;19:4298-309.
28. Yuan Y, Hilliard G, Ferguson T, Millhorn DE. Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. J Biol Chem 2003;278:15911-6.
29. Salnikow K, Donald SP, Bruick RK, Zhitkovich A, Phang JM, Kasprzak KS. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J Biol Chem 2004;279:40337-44